TUTCRIS - Tampereen teknillinen yliopisto

TUTCRIS

Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer

Tutkimustuotosvertaisarvioitu

Standard

Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer. / Laitinen, Virpi H.; Rantapero, Tommi; Fischer, Daniel; Vuorinen, Elisa M.; Tammela, Teuvo L J; Wahlfors, Tiina; Schleutker, Johanna.

julkaisussa: International Journal of Cancer, Vuosikerta 136, Nro 10, 15.05.2015, s. 2316-2327.

Tutkimustuotosvertaisarvioitu

Harvard

Laitinen, VH, Rantapero, T, Fischer, D, Vuorinen, EM, Tammela, TLJ, Wahlfors, T & Schleutker, J 2015, 'Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer', International Journal of Cancer, Vuosikerta. 136, Nro 10, Sivut 2316-2327. https://doi.org/10.1002/ijc.29276

APA

Laitinen, V. H., Rantapero, T., Fischer, D., Vuorinen, E. M., Tammela, T. L. J., Wahlfors, T., & Schleutker, J. (2015). Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer. International Journal of Cancer, 136(10), 2316-2327. https://doi.org/10.1002/ijc.29276

Vancouver

Laitinen VH, Rantapero T, Fischer D, Vuorinen EM, Tammela TLJ, Wahlfors T et al. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer. International Journal of Cancer. 2015 touko 15;136(10):2316-2327. https://doi.org/10.1002/ijc.29276

Author

Laitinen, Virpi H. ; Rantapero, Tommi ; Fischer, Daniel ; Vuorinen, Elisa M. ; Tammela, Teuvo L J ; Wahlfors, Tiina ; Schleutker, Johanna. / Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer. Julkaisussa: International Journal of Cancer. 2015 ; Vuosikerta 136, Nro 10. Sivut 2316-2327.

Bibtex - Lataa

@article{7a05e522ba7a4879ba8d94bbfb7b8db3,
title = "Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer",
abstract = "The 2q37 and 17q12-q22 loci are linked to an increased prostate cancer (PrCa) risk. No candidate gene has been localized at 2q37 and the HOXB13 variant G84E only partially explains the linkage to 17q21-q22 observed in Finland. We screened these regions by targeted DNA sequencing to search for cancer-associated variants. Altogether, four novel susceptibility alleles were identified. Two ZNF652 (17q21.3) variants, rs116890317 and rs79670217, increased the risk of both sporadic and hereditary PrCa (rs116890317: OR = 3.3-7.8, p = 0.003-3.3 × 10-5; rs79670217: OR = 1.6-1.9, p = 0.002-0.009). The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa. To map the variants within 2q37 and 17q11.2-q22 that may regulate PrCa-associated genes, we combined DNA sequencing results with transcriptome data obtained by RNA sequencing. This expression quantitative trait locus (eQTL) analysis identified 272 single-nucleotide polymorphisms (SNPs) possibly regulating six genes that were differentially expressed between cases and controls. In a modified approach, prefiltered PrCa-associated SNPs were exploited and interestingly, a novel eQTL targeting ZNF652 was identified. The novel variants identified in this study could be utilized for PrCa risk assessment, and they further validate the suggested role of ZNF652 as a PrCa candidate gene. The regulatory regions discovered by eQTL mapping increase our understanding of the relationship between regulation of gene expression and susceptibility to PrCa and provide a valuable starting point for future functional research.",
keywords = "17q11.2-q22, 2q37, genetic predisposition, prostate cancer risk, susceptibility loci",
author = "Laitinen, {Virpi H.} and Tommi Rantapero and Daniel Fischer and Vuorinen, {Elisa M.} and Tammela, {Teuvo L J} and Tiina Wahlfors and Johanna Schleutker",
year = "2015",
month = "5",
day = "15",
doi = "10.1002/ijc.29276",
language = "English",
volume = "136",
pages = "2316--2327",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley",
number = "10",

}

RIS (suitable for import to EndNote) - Lataa

TY - JOUR

T1 - Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer

AU - Laitinen, Virpi H.

AU - Rantapero, Tommi

AU - Fischer, Daniel

AU - Vuorinen, Elisa M.

AU - Tammela, Teuvo L J

AU - Wahlfors, Tiina

AU - Schleutker, Johanna

PY - 2015/5/15

Y1 - 2015/5/15

N2 - The 2q37 and 17q12-q22 loci are linked to an increased prostate cancer (PrCa) risk. No candidate gene has been localized at 2q37 and the HOXB13 variant G84E only partially explains the linkage to 17q21-q22 observed in Finland. We screened these regions by targeted DNA sequencing to search for cancer-associated variants. Altogether, four novel susceptibility alleles were identified. Two ZNF652 (17q21.3) variants, rs116890317 and rs79670217, increased the risk of both sporadic and hereditary PrCa (rs116890317: OR = 3.3-7.8, p = 0.003-3.3 × 10-5; rs79670217: OR = 1.6-1.9, p = 0.002-0.009). The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa. To map the variants within 2q37 and 17q11.2-q22 that may regulate PrCa-associated genes, we combined DNA sequencing results with transcriptome data obtained by RNA sequencing. This expression quantitative trait locus (eQTL) analysis identified 272 single-nucleotide polymorphisms (SNPs) possibly regulating six genes that were differentially expressed between cases and controls. In a modified approach, prefiltered PrCa-associated SNPs were exploited and interestingly, a novel eQTL targeting ZNF652 was identified. The novel variants identified in this study could be utilized for PrCa risk assessment, and they further validate the suggested role of ZNF652 as a PrCa candidate gene. The regulatory regions discovered by eQTL mapping increase our understanding of the relationship between regulation of gene expression and susceptibility to PrCa and provide a valuable starting point for future functional research.

AB - The 2q37 and 17q12-q22 loci are linked to an increased prostate cancer (PrCa) risk. No candidate gene has been localized at 2q37 and the HOXB13 variant G84E only partially explains the linkage to 17q21-q22 observed in Finland. We screened these regions by targeted DNA sequencing to search for cancer-associated variants. Altogether, four novel susceptibility alleles were identified. Two ZNF652 (17q21.3) variants, rs116890317 and rs79670217, increased the risk of both sporadic and hereditary PrCa (rs116890317: OR = 3.3-7.8, p = 0.003-3.3 × 10-5; rs79670217: OR = 1.6-1.9, p = 0.002-0.009). The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa. To map the variants within 2q37 and 17q11.2-q22 that may regulate PrCa-associated genes, we combined DNA sequencing results with transcriptome data obtained by RNA sequencing. This expression quantitative trait locus (eQTL) analysis identified 272 single-nucleotide polymorphisms (SNPs) possibly regulating six genes that were differentially expressed between cases and controls. In a modified approach, prefiltered PrCa-associated SNPs were exploited and interestingly, a novel eQTL targeting ZNF652 was identified. The novel variants identified in this study could be utilized for PrCa risk assessment, and they further validate the suggested role of ZNF652 as a PrCa candidate gene. The regulatory regions discovered by eQTL mapping increase our understanding of the relationship between regulation of gene expression and susceptibility to PrCa and provide a valuable starting point for future functional research.

KW - 17q11.2-q22

KW - 2q37

KW - genetic predisposition

KW - prostate cancer risk

KW - susceptibility loci

UR - http://www.scopus.com/inward/record.url?scp=84924310013&partnerID=8YFLogxK

U2 - 10.1002/ijc.29276

DO - 10.1002/ijc.29276

M3 - Article

VL - 136

SP - 2316

EP - 2327

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 10

ER -